Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets.


Updates from The Motley Fool

Latest updates on Transition Therapeutics from Fool.com.


Stock Performance

TTHI vs. S&P 500 | 2 Year Performance
View Interactive TTHI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Transition Therapeutics.
Current Price: $1.48
Prev Close: $1.52
Open: $1.53
Bid: $1.40
Ask: $3.20
Day's Range: $1.48 - $1.56
52wk Range: $0.66 - $2.75
Volume: 37,397
Avg Vol 43,092
Market Cap: $57.54M
P/E (ttm): -1.42
EPS (ttm): -$1.07
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Transition Therapeutics.
CAPS Rating 3 out of 5
 
49 Outperform
13 Underperform
CAPS All Stars
 
10 Outperform
6 Underperform

How do you think Transition Therapeutics will perform against the market?



You pick for Transition Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Transition Therapeutics.

Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers